ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

JNJ vs PM // NET PROFIT MARGIN

Johnson & Johnson (NYSE) VS. Philip Morris International Inc (NYSE) • 15-METRIC TALLY: JNJ 7 — PM 7
▲ NET PROFIT MARGIN LEADER: JNJ
net-margins
28.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JNJ VS. PM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC JNJ PM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 67.90% 67.10% +0.80 JNJ /gross-margins <GO>
Return on Invested Capital (ROIC) 25.50% 45.30% -19.80 PM /roic <GO>
EV/EBITDA & P/E Valuation 18.5x 21.7x -3.20 JNJ /valuation <GO>
Free Cash Flow Yield 2.97% 3.28% -0.31 PM /fcf-yield <GO>
Operating Margin 34.70% 36.60% -1.90 PM /operating-margins <GO>
Net Profit Margin ACTIVE 28.50% 27.90% +0.60 JNJ /net-margins <GO>
Revenue Growth (YoY) 6.00% 7.30% -1.30 PM /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.65% -2.65 PM /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.59 4.52 +1.07 JNJ /balance-sheet <GO>
Piotroski F-Score Quality 8/9 8/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew 7.20% 6.70% +0.50 PM /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 60.4 64.5 -4.14 PM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.08 0.93 +0.15 JNJ /macro-sensitivity <GO>
Forward P/E Multiple 23.0x 26.6x -3.60 JNJ /forward-pe <GO>
Enterprise Scale & Market Cap $662.49B $324.98B $337.51B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR JNJ REV PM REV JNJ GROSS % PM GROSS % JNJ FCF PM FCF
FY 2025 $94.19B $40.65B 67.9% 67.1% $19.70B $10.66B
FY 2024 $88.82B $37.88B 69.1% 64.8% $19.84B $10.77B
FY 2023 $85.16B $35.17B 44.0% 44.0% $18.96B $7.62B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JNJ // BETA 1.08
PM // BETA 0.93